Cargando…
Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study
BACKGROUND: The autoimmune profile of Chronic Urticaria (CU) patients is an increasing topic of interest. Associated diseases suggest shared pathogenic pathways, and they may provide important knowledge on specific targets for future treatment models. In this study we examined the prevalence and ris...
Autores principales: | Ghazanfar, Misbah Noshela, Kibsgaard, Line, Thomsen, Simon Francis, Vestergaard, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994395/ https://www.ncbi.nlm.nih.gov/pubmed/32021661 http://dx.doi.org/10.1016/j.waojou.2019.100097 |
Ejemplares similares
-
Occurrence and risk factors of mental disorders in patients with chronic urticaria
por: Ghazanfar, Misbah Noshela, et al.
Publicado: (2023) -
Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria
por: Pedersen, Nadja Højgaard, et al.
Publicado: (2023) -
Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies
por: Ghazanfar, Misbah Nasheela, et al.
Publicado: (2015) -
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study
por: Ghazanfar, Misbah Noshela, et al.
Publicado: (2022) -
A Case Series Study of Eighty-Five Chronic Spontaneous Urticaria Patients Referred to a Tertiary Care Center
por: Kibsgaard, Line, et al.
Publicado: (2014)